Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? ARCA biopharma, Inc.
Arca Biopharma shares soared 47.21 percent on volume of 2.35 million shares traded Monday to close at $2.90. The company announced that it will collaborate with Medtronic on Arca’s proposed atrial fibrillation clinical trial of Gencaro. Shares of the company are up approximately 27 percent year-to-date.
Going forward ... (see research report)
Subscribe to News Feeds